Exploring Clinical Trial Experiences of People With Leiomyosarcoma
Not yet recruiting
- Conditions
- Leiomyosarcoma
- Registration Number
- NCT05548179
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical study participation has historically been heavily biased toward specific demographics.
Several people will be invited to enroll in this study so that it may collect a variety of data about leiomyosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.
People with leiomyosarcoma who are invited to take part in medical research will benefit from the analysis of the data.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Patient has self-identified as planning to enroll in an interventional clinical trial
- Patient has been diagnosed with leiomyosarcoma
- Patient is a minimum of 18 years or older
Exclusion Criteria
- Patient does not understand, sign, and return consent form
- Inability to perform regular electronic reporting
- Patient is pregnant
- ECOG score of 4
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients who decide to enroll in an leiomyosarcoma clinical trial 3 months Rate of patients who remain in leiomyosarcoma clinical trial to trial completion 12 months
- Secondary Outcome Measures
Name Time Method